VERORAB INJ PSU LQF 1 + 1X0,5 ML ISP

What is the maximum co-payment for VERORAB?

If the insurance company contributes, the maximum co-payment is 0,00 Kč. The maximum pharmacy price is 1 906,46 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.

Does VERORAB have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

1 906,46 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe VERORAB?

Prescription is not conditional on a medical specialization.

What is the composition of VERORAB?

Inaktivovaný virus vztekliny (2,5 iu), lidský albumin, maltosa, kyselina chlorovodíková, solution hydroxidu sodného, chlorid sodný, voda pro injekci (0,5 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to VERORAB?

The medicine belongs to ATC group J07BG01 – VZTEKLINA, INAKTIVOVANÝ CELÝ VIRUS. Medicines with the same active substance can be found here.

Who manufactures VERORAB?

Sanofi Winthrop Industrie, Gentilly (F)

Is the medicine in shortage?

The latest report from the manufacturer is from 20. 5. 2025. Production was terminated with effect from 20. 5. 2025. The manufacturer lists medicines with the following code as a potential substitute: